Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function

Neuropharmacology

Volumn 86, Issue , 2014, Pages 273-281

  Izumi, Yukitoshi ^a   Zorumski, Charles F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Memory; Modulation; Nitric oxide; NMDA receptor; Psychosis; Synaptic plasticity

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 (N ETHYL N PHENYLAMINO) 1,2 DIMETHYL 6 (METHYLAMINO)PYRIMIDINIUM CHLORIDE; AMPA RECEPTOR; FINASTERIDE; IFENPRODIL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NITRIC OXIDE SYNTHASE; AMINO ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE;

ANESTHESIA MECHANISM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; METAPLASTICITY; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BLOCKING; ANIMAL EXPERIMENT; DENDRITE; DRUG EFFECT; DRUG EXPOSURE; INHIBITION KINETICS; ANIMAL; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPSE; TISSUE CULTURE TECHNIQUE;

ANIMALS; CA1 REGION, HIPPOCAMPAL; DENDRITES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; KETAMINE; LONG-TERM POTENTIATION; LONG-TERM SYNAPTIC DEPRESSION; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES; TISSUE CULTURE TECHNIQUES;

EID: 84907316652     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.08.002     Document Type: Article

References (65)

1. M. aan het Rot, C. Zarate, D.S. Charney, and S.J. Mathew Ketamine for depression: where do we go from here? Biol. Psychiatry 72 2012 537 547
2. W.C. Abraham Metaplasticity: tuning synapses and networks for plasticity Nat. Rev. Neurosci. 9 2008 387 399 (Pubitemid 351556041)
3. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, P.-F. Cheng, E.T. Kavalali, and L.M. Monteggia NMDA receptor blockade at rest triggers rapid behavioral antidepressant responses Nature 475 2011 91 95
4. W.E. Babiec, R. Guglietta, S.A. Jami, W. Morishita, R.C. Malenka, and T.J. O'Dell Ionotropic NMDA receptor signaling is required for the induction of long-term depression in the mouse hippocampal CA1 region J. Neurosci. 34 2014 5285 5290
5. T.E. Bartlett, N.J. Bannister, V.J. Collett, S.L. Dargan, P.V. Massey, Z.A. Bortolotto, S.M. Fitzjohn, Z.I. Bashir, G.L. Collingridge, and D. Lodge Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus Neuropharmacology 52 2007 60 70 (Pubitemid 46026825)
6. M.M. Behrens, S.S. Ali, D.N. Dao, J. Lucero, G. Shekhtman, K.L. Quck, and L.L. Dugan Ketamine-induced loss of phenotype of fast spiking interneurons is mediated by NADPH-oxidase Science 318 2007 1645 1647 (Pubitemid 350233667)
7. S. Berberich, P. Punnakkal, V. Jensen, V. Pawlak, P.H. Seeburg, O. Hvalby, and G. Kohr Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation J. Neurosci. 25 2005 6907 6910 (Pubitemid 41023158)
8. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, D.S. Charney, and J.H. Krystal Antidepressant effects of ketamine in depressed patients Biol. Psychiatry 47 2000 351 354 (Pubitemid 30109248)
9. E. Bettini, A. Sava, C. Griffante, C. Carignani, A. Buson, A.M. Capelli, M. Negri, F. Andreetta, S.A. Senar-Sancho, L. Guiral, and F. Cardullo Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors J. Pharmacol. Exp. Ther. 335 2010 636 644
10. A. Boultadakis, and N. Pitsikas Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat Neuropsychopharmacol 35 2010 2357 2366
11. A. Boultadakis, and N. Pitsikas Anesthetic ketamine impairs rats' recall of previous information: the nitric oxide inhibitor N-nitro-L-arginine methylester antagonizes this ketamine-induced recognition memory deficit Anesthesiology 114 2011 1345 1353
12. X. Chen, S. Shu, and D.A. Bayliss HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine J. Neurosci. 29 2009 600 609
13. M. Chisari, C.F. Zorumski, and S. Mennerick Cross talk between synaptic receptors mediates NMDA-induced suppression of inhibition J. Neurophysiol. 107 2012 2532 2540
14. M.L. Cohen, S.-L. Chan, W. Way, and A. Trevor Distribution in the brain and metabolism of ketamine in the rat after intravenous administration Anesthesiology 39 1973 370 376
15. M.V. Doucet, A. Harkin, and K.K. Dev The PSD-95/nNOS complex: new drugs for depression? Pharmacol. Ther. 133 2013 218 229
16. O.M. Doyle, S. De Simoni, A.J. Schwarz, C. Brittain, O.G. O'Daly, S.C.R. Williams, and M.A. Mehta Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents J. Pharmacol. Exp. Ther. 345 2013 151 160
17. C.M. Emnett, L.N. Eisenman, A.M. Taylor, Y. Izumi, C.F. Zorumski, and S. Mennerick Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine Mol. Pharmacol. 84 2013 935 947
18. N. Gass, A.J. Schwarz, A. Sartorius, E. Schenker, C. Risterucci, M. Spedding, L. Zheng, A. Meyer-Lindenberg, and W. Weber-Fahr Sub-anesthetic ketamine modulates intrinsic BOLD connectivity within the hippocampal-prefrontal circuit in the rat Neuropsychopharmacology 39 2014 895 906
19. J.A. Gray, Y. Shi, H. Usui, M.J. During, K. Sakimura, and R.A. Nicoll Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo Neuron 71 2011 1085 1101
20. N.C. Harris, and A. Constanti Mechanism of block by ZD 7288 of the hyperpolarization-activated inward rectifying current in guinea pig substantia nigra neurons in vitro J. Neurophysiol. 74 1995 2366 2378 (Pubitemid 26012299)
21. P. Hartvig, J. Valtysson, K.-J. Lindner, J. Kristensen, R. Karlsten, L.L. Gustafsson, J. Persson, J.O. Svensson, I. Oye, G. Antoni, G. Westerberg, and B. Langstrom Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers Clin. Pharmacol. Ther. 58 1995 165 173
22. J.E. Huettner, and B.P. Bean Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels Proc. Natl. Acad. Sci. U. S. A. 85 1988 1307 1311 (Pubitemid 18073998)
23. S.R. Hulme, O.C. Jones, and W.C. Abraham Emerging roles of metaplasticity in behavior and disease Trends Neurosci. 36 2013 353 362
24. Y. Izumi, Y.P. Auberson, and C.F. Zorumski Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors J. Neurosci. 26 2006 7181 7188
25. Y. Izumi, D.B. Clifford, and C.F. Zorumski Low concentrations of N-methyl-D-aspartate inhibit the induction of long-term potentiation in rat hippocampal slices Neurosci. Lett. 137 1992 245 248
26. Y. Izumi, D.B. Clifford, and C.F. Zorumski Inhibition of long-term potentiation by NMDA-mediated nitric oxide release Science 257 1992 1273 1276
27. Y. Izumi, K. Nagashima, K. Murayama, and C.F. Zorumski Acute effects of ethanol on hippocampal LTP and LTD are mediated by different mechanisms Neuroscience 136 2005 509 517 (Pubitemid 41607899)
28. Y. Izumi, K. Tokuda, K.A. O'Dell, C.F. Zorumski, and T. Narahashi Neuroexcitatory actions of tamiflu and its carboxylate metabolite Neurosci. Lett. 426 2007 54 58 (Pubitemid 47444506)
29. Y. Izumi, K. Tokuda, and C.F. Zorumski Long-term potentiation inhibition by low-level N-methyl-D-aspartate receptor activation involves calcineurin, nitric oxide and p38 mitogen-activated protein kinase Hippocampus 18 2008 258 265 (Pubitemid 351399629)
30. Y. Izumi, and C.F. Zorumski NMDA receptors, mGluR5 and endocannabinoids are involved in a cascade leading to hippocampal long-term depression Neuropsychopharmacology 37 2012 609 617
31. K. Kato, S.T. Li, and C.F. Zorumski Modulation of long-term potentiation induction in the hippocampus by N-methyl-D-aspartate-mediated presynaptic inhibition Neuroscience 92 1999 1261 1272 (Pubitemid 29292563)
32. E.T. Kavalali, and L.M. Monteggia Synaptic mechanisms underlying rapid antidepressant action of ketamine Am. J. Psychiatry 169 2012 1150 1156
33. 2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine J. Neurosci. 29 2009 2774 2779
34. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, J.D. Bremner, G.R. Heninger, M.B. Bowers, and D.S. Charney Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive and neuroendocrine responses Arch. Gen. Psychiatry 51 1994 199 214 (Pubitemid 24081509)
35. J.H. Krystal, I.L. Petrakis, D. Limoncelli, E. Webb, R. Gueorgueva, D.C. D'Souza, N.N. Boutros, L. Trevisan, and D.S. Charney Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients Neuropsychopharmacology 28 2003 2020 2028 (Pubitemid 37412111)
36. J.H. Krystal, I.L. Petrakis, E. Webb, N.L. Cooney, L.P. Karper, S. Namanworth, P. Stetson, L.A. Trevisan, and D.S. Charney Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics Arch. Gen. Psychiatry 55 1998 354 360 (Pubitemid 28173625)
37. N. Li, B. Lee, R.-J. Liu, M. Banasr, J.M. Dwyer, M. Iwata, X.-Y. Li, G. Aghajanian, and R.S. Duman mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 329 2010 959 964
38. L. Liu, T.P. Wong, M.F. Pozza, K. Lingenhoehl, Y. Wang, M. Sheng, Y.P. Auberson, and Y.T. Wang Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity Science 304 2004 1021 1024 (Pubitemid 38638102)
39. J.F. MacDonald, Z. Miljkovic, and P. Pennefather Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine J. Neurophysiol. 58 1987 251 266 (Pubitemid 17153969)
40. R. Machado-Vieira, G. Salvadore, N. Diazgranados, and C.A. Zarate Ketamine and the next generation of antidepressants with a rapid onset of action Pharmacol. Ther. 123 2009 143 150
41. J.C. Magee Dendritic integration of excitatory synaptic input Nat. Rev. Neurosci. 1 2000 181 190
42. R.C. Malenka, and M.F. Bear LTP and LTD: an embarrassment of riches Neuron 44 2004 5 12
43. D. Manahan-Vaughan, D. von Haebler, C. Winter, G. Juckel, and U. Heinemann A single application of MK-801 causes symptoms of psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats Hippocampus 18 2008 125 134 (Pubitemid 351413480)
44. P.V. Massey, B.E. Johnson, P.R. Moult, Y.P. Auberson, M.W. Brown, E. Molnar, G.L. Collingridge, and Z.I. Bashir Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression J. Neurosci. 24 2004 7821 7828 (Pubitemid 39215685)
45. S. Nabavi, H.W. Kessels, S. Alfonso, J. Aow, R. Fox, and R. Malinow Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression Proc. Natl. Acad. Sci. U. S. A. 110 2013 4027 4032
46. K. Nagashima, C.F. Zorumski, and Y. Izumi Nitrous oxide (laughing gas) facilitates excitability in rat hippocampal slices through g-aminobutyric acid A receptor-mediated disinhibition Anesthesiology 102 2005 230 234 (Pubitemid 40082861)
47. J.W. Newcomer, N.B. Farber, V. Jevtovic-Todorovic, G. Selke, A.K. Melson, T. Hershey, S. Craft, and J.W. Olney Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis Neuropsychopharmacology 20 1999 106 118 (Pubitemid 29010370)
48. E. Nosyreva, K. Szabla, A.E. Autry, A.G. Ryazanov, L.M. Monteggia, and E. Kavalali Acute suppression of spontaneous neurotransmission drives synaptic potentiation J. Neurosci. 33 2013 6990 7002
49. E. Palsson, J. Lowry, and D. Klamer Information processing defects and nitric oxide signaling in the phencyclidine model of schizophrenia Psychopharmacology 212 2010 643 651
50. P. Paoletti, C. Bellone, and Q. Zhou NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease Nat. Rev. Neurosci. 14 2013 383 400
51. L.E. Phelps, N. Brutsche, J.R. Moral, D.A. Luckenbaugh, H. Manji, and C.A. Zarate Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist Biol. Psychiatry 65 2009 181 184
52. T. Priestley, P. Laughton, J. Myers, B. Le Bourdelles, J. Kerby, and P.J. Whiting Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells Mol. Pharmacol. 48 1995 841 848
53. S.A. Schobel, N.H. Chaudhury, U.A. Khan, B. Paniagua, M.A. Styner, I. Asllani, B.P. Inbar, C.M. Corcoran, J.A. Lieberman, H. Moore, and S.A. Small Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver Neuron 78 2013 81 93
54. S. Sorce, S. Schiavone, P. Tucci, M. Colaianna, V. Jaquet, V. Cuomo, M. Dubois-Dauphin, L. Trabace, and K.H. Krause The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses J. Neurosci. 30 2010 11317 11325
55. K. Tokuda, Y. Izumi, and C.F. Zorumski Ethanol enhances neurosteroidogenesis in hippocampal pyramidal neurons by paradoxical NMDA receptor activation J. Neurosci. 31 2011 9905 9909
56. K. Tokuda, K.A. O'Dell, Y. Izumi, and C.F. Zorumski Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis J. Neurosci. 30 2010 16788 16795
57. K.R. Tovar, M.J. McGinley, and G.L. Westbrook Triheteromeric NMDA receptors at hippocampal synapses J. Neurosci. 33 2013 9150 9160
58. K.R. Tovar, and G.L. Westbrook The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro J. Neurosci. 19 1999 4180 4188 (Pubitemid 29222289)
59. R. Trullas, and P. Skolnick Functional antagonists at the NMDA receptor complex exhibit antidepressant actions Eur. J. Pharmacol. 185 1990 1 10 (Pubitemid 20254891)
60. S.P. Vaidya, and D. Johnston Temporal synchrony and gamma to theta power conversion in the dendrites of CA1 pyramidal neurons Nat. Neurosci. 16 2013 1812 1820
61. C. Wass, T. Archer, E. Palsson, K. Fejgin, D. Klamer, J.A. Engel, and L. Svensson Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent mechanisms Behav. Brain Res. 171 2006 147 153 (Pubitemid 43728400)
62. P.-C. Yang, C.-H. Yang, C.-C. Huang, and K.-S. Hsu Phosphatidylinositol 3-kinase activation is required for stress protocol-induced modification of hippocampal synaptic plasticity J. Biol. Chem. 283 2008 2631 2643
63. C.A. Zarate, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, D.A. Luckenbaugh, D.S. Charney, and H.K. Manji A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch. Gen. Psychiatry 63 2006 856 864 (Pubitemid 44188478)
64. X. Zhao, S.L.V. Venkata, R. Moaddel, D.A. Luckenbaugh, N.E. Brutsche, L. Ibrahim, C.A. Zarate, D.E. Mager, and I.W. Wainer Simultaneous population pharmacokinetic modeling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression Br. J. Clin. Pharmacol. 74 2012 304 314
65. C.F. Zorumski, and Y. Izumi NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders Neurosci. Biobehav. Rev. 36 2012 989 1000